$PFE Swing Trader: 5.49% Gain from Deep TA & Trend Analysis
Deep Trend Analysis (TA) Generates 5.49% for Pfizer (PFE) with Swing Trading
Swing trading is a renowned strategy used by countless investors worldwide. It is a short-term trading method that aims to capture gains within a span of days or weeks, leveraging the technical analysis of a company's stocks. A compelling instance of this is the deep trend analysis (TA) generating a 5.49% return on Pfizer Inc. (PFE).
The application of the Relative Strength Index (RSI) - a critical technical indicator for swing traders, was instrumental in this case. RSI measures the speed and change of price movements, often used to identify overbought or oversold conditions in a market. For PFE, the RSI indicator was seen ascending from the oversold territory.
An oversold condition is typically a signal that the market has been heavily bearish for a period, pushing prices down to extremely low levels. When the RSI ascends from this territory, it implies a potential trend reversal, offering an optimal moment for traders to step in. In the case of PFE, traders who recognized this shift and made timely trades would have benefited from a substantial 5.49% gain.
Beyond its application in identifying potential market reversals, RSI is also efficient at recognizing general market trends. In the context of PFE, the RSI's upward movement from the oversold territory also illustrated a broader upward price trend. It served as a definitive testament to the value of deep trend analysis, underlining the power of technical indicators in swing trading.
While the technical indicators and analysis methods are essential tools for any swing trader, it's equally important to understand the context behind these movements. Pfizer, a leading global pharmaceutical company, has been at the forefront of medical breakthroughs and developments. The deep trend analysis for PFE aligns with the company's strong performance, contributing to its advantageous position in the market.
The 5.49% return from swing trading in PFE is a clear testament to the significance and potential of technical analysis in successful short-term trading strategies. This profitable venture reaffirms that with vigilant monitoring, accurate interpretations, and timely decisions, swing trading can indeed be a fruitful exercise for investors.
PFE in +1.34% Uptrend, rising for three consecutive days on May 30, 2025
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PFE advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on PFE as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
PFE moved above its 50-day moving average on May 29, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PFE crossed bullishly above the 50-day moving average on May 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PFE broke above its upper Bollinger Band on April 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.763) is normal, around the industry mean (5.632). P/E Ratio (74.919) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.281) is also within normal values, averaging (3.004). Dividend Yield (0.060) settles around the average of (0.161) among similar stocks. P/S Ratio (2.674) is also within normal values, averaging (3.643).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PFE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PFE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of vaccines and injectable biologic medicines
Industry PharmaceuticalsMajor
Advertisement